-transparent.png){kind=logo}
A benzodiazepine antagonist, RO15-1788, was administered intragastrically to diazepam-dependent gastric fistula rats and a precipitated abstinence syndrome was observed. The intensity of the RO15-1788 precipitated abstinence syndrome, calculated by the Precipitated Abstinence Scale, increased in intensity in a log-dose manner over a dose range of 1.0 to 15.0 mg/kg of RO15-1788 and plateaued at the 15.0 mg/kg dose. The RO15-1788 precipitated diazepam abstinence syndrome differed both qualitatively and quantitatively from the diazepam withdrawal syndrome.
Related Publications
L F McNicholas, and
W R Martin
February 1985,
Life sciences,
L F McNicholas, and
W R Martin
May 1986,
Acta anaesthesiologica Scandinavica,
L F McNicholas, and
W R Martin
August 1985,
Lancet (London, England),
L F McNicholas, and
W R Martin
May 1982,
Neuropharmacology,
L F McNicholas, and
W R Martin
June 1985,
Neuroscience,
L F McNicholas, and
W R Martin
June 1986,
Pharmacology, biochemistry, and behavior,
L F McNicholas, and
W R Martin
November 1983,
Pharmacology, biochemistry, and behavior,
L F McNicholas, and
W R Martin
June 1990,
Masui. The Japanese journal of anesthesiology,
L F McNicholas, and
W R Martin
June 1983,
European journal of pharmacology,
L F McNicholas, and
W R Martin
March 1988,
Journal of anesthesia,
